Alexander Mustea

Alexander Mustea

UNVERIFIED PROFILE

Are you Alexander Mustea?   Register this Author

Register author
Alexander Mustea

Alexander Mustea

Publications by authors named "Alexander Mustea"

Are you Alexander Mustea?   Register this Author

75Publications

1750Reads

10Profile Views

Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenyls.

Invest New Drugs 2020 Apr 11;38(2):541-545. Epub 2019 Jul 11.

Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-019-00833-0DOI Listing
April 2020

Cold Atmospheric Plasma Treatment of Chondrosarcoma Cells Affects Proliferation and Cell Membrane Permeability.

Int J Mol Sci 2020 Mar 26;21(7). Epub 2020 Mar 26.

Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21072291DOI Listing
March 2020

Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.

Gynecol Oncol 2019 05 11;153(2):286-291. Epub 2019 Feb 11.

Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Germany; Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.02.007DOI Listing
May 2019

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.

N Engl J Med 2019 02;380(9):822-832

From the Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen (P. Harter, A. du Bois), Department of Gynecology, Charité-Universitätsmedizin Berlin, Berlin (J.S.), the Coordinating Center for Clinical Trials, Philipps University Marburg (A.R., C.S.-B.), and the Department of Gynecology and Obstetrics, University Hospital Giessen and Marburg (U.W.), Marburg, the Department of Gynecology and Obstetrics, Kaiserswerther Diakonie (B.L.), and the Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf (W.M.), Düsseldorf, the Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald (A.M.), the Department of Gynecology, University Medical Center Hamburg-Eppendorf (S.M.), and the Department of Gynecology and Obstetrics, Albertinen Krankenhaus (I.L.), Hamburg, University Women's Hospital, Department of Gynecology and Reproductive Medicine and Center for Gynecologic Oncology, Jena University Hospital, Jena (I.B.R.), the Department of Obstetrics and Gynecology, University Munich rechts der Isar (B.S.), and the Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-Universität München (A. Burges), Munich, West German Cancer Center, Department of Gynecology and Obstetrics, University of Duisburg-Essen, Duisburg (R.K.), the Department of Gynecology and Obstetrics, University Hospital Kiel, Kiel (F.H.), University Medical Center Freiburg, Freiburg (A.H.), University Medical Center Mainz, Department of Gynecology and Obstetrics, Mainz (A.H.), and the Department of Gynecology and Obstetrics, Hannover Medical School, Hannover (P. Hillemanns) - all in Germany; the Gynecologic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (D.L., F.R.), and the Department of Gynecologic Oncology, European Institute of Oncology, University of Milan (G.A.), Milan, the Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome (G.S.), Gynecologic Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli, IRCCS Fondazione G. Pascale, Naples (S.G.), and the Cancer Reference Center, Centro di Riferimento Oncologico, Aviano (G.G.) - all in Italy; the Department of Gynecological Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium (I.V.); the Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria (C.M.); the Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea (J.-W.K.); and the Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic (D.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1808424DOI Listing
February 2019

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.

Geburtshilfe Frauenheilkd 2018 Nov 26;78(11):1089-1109. Epub 2018 Nov 26.

Klinik für Gynäkologie und Geburtshilfe, Universitätsmedizin Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0715-2964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261739PMC
November 2018

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.

Geburtshilfe Frauenheilkd 2018 Oct 19;78(10):949-971. Epub 2018 Oct 19.

Klinik für Gynäkologie und Geburtshilfe, Universitätsmedizin Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/a-0713-1218
Publisher Site
http://dx.doi.org/10.1055/a-0713-1218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195426PMC
October 2018

Statement of the Uterus Committee of the Gynaecological Oncology Working Group (AGO) on the PORTEC-3 study.

Geburtshilfe Frauenheilkd 2018 Oct 19;78(10):923-926. Epub 2018 Oct 19.

Universitätsklinik Halle (Saale), Halle (Saale), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0658-1918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195428PMC
October 2018

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

Br J Cancer 2018 08 29;119(3):330-338. Epub 2018 Jun 29.

Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0157-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070919PMC
August 2018

Functionality of the Tumor Suppressor in Malignant Tissue and Cell Line Cells of Uterine Leiomyosarcoma.

Anticancer Res 2018 03;38(3):1547-1550

Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12383DOI Listing
March 2018

Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.

Int J Gynecol Cancer 2017 03;27(3):500-506

*Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald; †Department of Gynecology and Gynecological Oncology, Charité Berlin, Berlin; ‡Department of Urology, University Medicine Greifswald, Greifswald; §Department of Obstetrics and Gynecology, University Hospital Heidelberg; and ∥Department of Obstetrics and Gynecology, Städtisches Klinikum Brandenburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000894DOI Listing
March 2017

The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.

Arch Gynecol Obstet 2016 11 14;294(5):889-895. Epub 2016 Sep 14.

Department of Gynaecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-016-4194-7DOI Listing
November 2016

Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.

Mol Med Rep 2016 Aug 23;14(2):1465-74. Epub 2016 Jun 23.

Gynecological Tumor Center, Department of Obstetrics and Gynecology, Medical University Greifswald, D‑17475 Greifswald, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2016.5435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940087PMC
August 2016

Drug-induced Modulation of Heat Shock Protein HSPB1 in an Ovarian Cancer Cell Model.

Anticancer Res 2016 Jul;36(7):3321-7

Department of Obstetrics and Gynaecology, University of Medicine Greifswald, Greifswald, Germany.

View Article

Download full-text PDF

Source
July 2016

The Tumor Suppressor MicroRNA-1 Exhibits Restricted Inhibition of Proliferation of Ovarian Cancer Cells.

Anticancer Res 2016 Jul;36(7):3329-34

Department of Gynecology and Obstetrics, University of Medicine Greifswald, Greifswald, Germany.

View Article

Download full-text PDF

Source
July 2016

The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.

Arch Gynecol Obstet 2016 Apr 19;293(4):695-700. Epub 2016 Feb 19.

Klinik für Gynäkologie und Geburtsmedizin, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00404-016-4035-8
Publisher Site
http://dx.doi.org/10.1007/s00404-016-4035-8DOI Listing
April 2016

Acupuncture for pain control after Caesarean section: a prospective observational pilot study.

Acupunct Med 2016 Feb 25;34(1):14-9. Epub 2015 Aug 25.

Department of Anaesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, University Medicine of Greifswald, Greifswald, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/acupmed-2015-010852DOI Listing
February 2016

Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.

Arch Gynecol Obstet 2015 Jul 26;292(1):231-4. Epub 2015 Apr 26.

Rotkreuzklinikum München, Frauenklinik, Taxisstraße 3, 80637, München, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-015-3697-yDOI Listing
July 2015

Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin.

Sarcoma 2015 18;2015:704124. Epub 2015 May 18.

Département de Medecine, Institut Gustave-Roussy, 114 rue Edouard Vaillant, 94805 Villejuif Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/704124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451518PMC
June 2015

Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.

J Natl Cancer Inst 2015 Mar 24;107(3). Epub 2015 Jan 24.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (SM, LFG, LW); Department of Obstetrics and Gynecology, University Hospital Munich Maistrasse, Munich, Germany (JJ); Department of Obstetrics and Gynecology, University Medical Center Kiel, Kiel, Germany (FH); KKS Philipps University Marburg, Marburg, Germany (PN); Department of Gynecology and Gynecologic Oncology Kliniken Essen-Mitte, Essen, Germany (PH, AdB); Department of Obstetrics and Gynecology, University of Ulm Medical Center, Ulm, Germany (NdG); Department of Gynecology and Gynecologic Oncology, University Hospital Freiburg, Freiburg, Germany (AHas); Department of Gynecology, Charité University Medicine Berlin Campus Virchow, Berlin, Germany (JS); Department of Obstetrics and Gynecology, University Hospital Magdeburg, Magdeburg, Germany (AHab); Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany (PH); Department of Obstetrics and Gynecology, Grosshadern University Hospital, Munich, Germany (SF); Department of Gynecology, University Hospital Halle, Halle, Germany (HGS); Department of Gynecology and Gynecologic Oncology, Philipps University Marburg, Marburg, Germany (KB); Department of Gynecology, University Hospital Erlangen, Erlangen, Germany (FT); Department of Obstetrics and Gynecology, University Hospital Greifswald, Greifswald, Germany (AM); Department of Obstetrics and Gynecology, Evangelical Hospital Duesseldorf, Duesseldorf, Germany (WM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356703PMC
March 2015

Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary.

J Cancer Res Clin Oncol 2013 Feb 23;139(2):347-55. Epub 2012 Oct 23.

Department of Gynecology and Obstetrics, University Medical Center RWTH, Pauwelsstrasse 30, 52074 Aachen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-012-1334-8
Publisher Site
http://dx.doi.org/10.1007/s00432-012-1334-8DOI Listing
February 2013

Tumor- and stromal cell-specific expression of topoisomerase IIα and HER-2/neu in primary and recurrent ovarian cancer: Results of a prospective study.

Mol Med Rep 2009 Nov-Dec;2(6):1011-6

Department of Obstetrics and Gynecology, Campus Virchow Clinic, Charité University Hospital, D-13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr_00000207DOI Listing
October 2012

Acupuncture does not influence brainstem auditory evoked potentials: a volunteer crossover study.

Acupunct Med 2011 Sep 26;29(3):215-20. Epub 2011 Apr 26.

Department of Anaesthesiology and Intensive Care Medicine, Ernst Moritz Arndt University of Greifswald, Friedrich Loeffler Strasse 23b, 17487 Greifswald, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/aim.2010.003327DOI Listing
September 2011

Expression and localization of e-cadherin in epithelial ovarian cancer.

Anticancer Res 2010 Jul;30(7):2525-30

Department of Gynecology and Obstetrics, Ernst Moritz Arndt University Hospital Greifswald, 17475 Greifswald, Germany.

View Article

Download full-text PDF

Source
July 2010

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.

Cancer Lett 2009 Jun 1;278(1):73-81. Epub 2009 Feb 1.

Tumor Immunology Programme, D015, German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.12.028DOI Listing
June 2009

KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.

BMC Cancer 2009 Apr 9;9:111. Epub 2009 Apr 9.

Division of Gynaecology, Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-9-111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671522PMC
April 2009

Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study.

Cytokine 2009 Jan 13;45(1):8-11. Epub 2008 Dec 13.

Department of Gynecology and Obstetrics, Charité Medical University of Berlin, Augustenburger Platz 1, Mittelallee 9, D-13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2008.10.019DOI Listing
January 2009

New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.

Crit Rev Oncol Hematol 2008 Sep 14;67(3):204-12. Epub 2008 Apr 14.

Department of Obstetrics and Gynecology, Charité University Hospital, Campus Virchow-Clinic, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2008.02.011DOI Listing
September 2008

Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO.

Cancer Chemother Pharmacol 2008 Feb 29;61(2):243-50. Epub 2007 Mar 29.

Department of Gynaecology and Gynaecologic Oncology, Charité Virchow University Hospital, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0466-zDOI Listing
February 2008

Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.

Gynecol Oncol 2007 Dec 27;107(3):563-71. Epub 2007 Sep 27.

Tumor Immunology Programme (D010), German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.08.064DOI Listing
December 2007

Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.

Gynecol Oncol 2007 Nov 14;107(2):266-73. Epub 2007 Aug 14.

Department of Obstetrics and Gynecology, Charité University Hospital, Campus Virchow, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.06.023DOI Listing
November 2007

Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.

Anticancer Res 2007 May-Jun;27(3B):1527-30

Department of Gynaecology and Obstetrics, Charité, Medical University of Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/27/3B/1527.full.pdf
Web Search
July 2007

The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.

Anticancer Res 2007 May-Jun;27(3B):1531-5

Department of Gynaecology and Obstetrics, Charité, Campus Virchow-Klinikum, Medical University of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
July 2007

Vascular endothelial growth factor gene polymorphisms in ovarian cancer.

Gynecol Oncol 2007 May 6;105(2):385-9. Epub 2007 Feb 6.

Department of Obstetrics and Gynecology, Medical University of Vienna, A-1090 Vienna, Währinger Gürtel 18-20, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.12.021DOI Listing
May 2007

Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients.

Gynecol Oncol 2007 Mar 1;104(3):680-5. Epub 2006 Dec 1.

Department of Gynecology and Obstetrics, Charité/Campus Virchow-Klinikum, Charité Medical University of Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.10.014DOI Listing
March 2007

The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.

Eur J Obstet Gynecol Reprod Biol 2007 Feb 7;130(2):249-57. Epub 2006 Mar 7.

Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University Health Science Center, Xizhimen South Street No. 11, 100044 Beijing, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2006.01.028DOI Listing
February 2007

Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.

Clin Cancer Res 2007 Feb;13(3):898-901

Department of Obstetrics and Gynecology and Core Unit for Medical Statistics and Informatics, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1008DOI Listing
February 2007

Options and limits of surgery after pre-operative chemotherapy in breast cancer.

Anticancer Res 2006 Mar-Apr;26(2C):1677-82

Department of Obstetrics and Gynecology, University Medicine Berlin, Charité Campus Mitte, Berlin, Germany.

View Article

Download full-text PDF

Source
May 2006

Expression of IL-10 in patients with ovarian carcinoma.

Anticancer Res 2006 Mar-Apr;26(2C):1715-8

Charité, Department of Obstetrics and Gynecology, Medical University Berlin, D - 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/26/2C/1715.full.pdf
Web Search
May 2006

Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.

BMC Cancer 2005 Oct 17;5:133. Epub 2005 Oct 17.

Department of Physiology and Pathophysiology, Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee 114-116, D-14558 Nuthetal, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-5-133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274304PMC
October 2005

Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells.

J Mol Med (Berl) 2005 Jun 16;83(6):457-67. Epub 2005 Mar 16.

Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University Health Science Center, 100044, Beijing, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-005-0639-3DOI Listing
June 2005

Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.

Anticancer Res 2004 Mar-Apr;24(2C):1223-9

Department of Obstetrics and Gynecology, Charité, Berlin, Germany.

View Article

Download full-text PDF

Source
June 2004

Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies.

Anticancer Res 2003 Sep-Oct;23(5b):4133-40

Department of Obstetrics and Gynaecology, Charité, Campus Virchow-Klinikum, Medical Faculty of the Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
December 2003

Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.

Cancer Epidemiol Biomarkers Prev 2003 Nov;12(11 Pt 1):1205-8

Department of Obstetrics and Gynaecology, Charité, Humboldt University, Berlin, Germany.

View Article

Download full-text PDF

Source
November 2003

Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.

Anticancer Res 2003 Mar-Apr;23(2A):1099-102

Charité, Department of Obstetrics and Gynaecology, Humboldt University, Augustenburger Platz 1, D-13353 Berlin, Germany.

View Article

Download full-text PDF

Source
July 2003

Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study.

Anticancer Res 2003 Mar-Apr;23(2A):1115-8

Charité, Department of Obstetrics and Gynaecology, Humboldt University, Augustenburger Platz 1, D-13353 Berlin, Germany.

View Article

Download full-text PDF

Source
July 2003

Polymorphism of IL-1 receptor antagonist gene: role in cancer.

Anticancer Res 2002 Nov-Dec;22(6A):3421-4

Department of Obstetrics and Gynaecology, Humboldt University, Augustenburger Platz 1, D-13353 Berlin, Germany.

View Article

Download full-text PDF

Source
January 2003

Interleukin-1 receptor antagonist gene polymorphism and cancer.

Clin Infect Dis 2002 Jun;34(11):1535-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/340530DOI Listing
June 2002